https://www.copyright link/companies/healthcare-and-fitness/the-five-pharma-stocks-exciting-investors-20240919-p5kbtv
Looks like the article is copyright. AFR article The five pharma stocks exciting investors
Some big companies mentioned CSL, NEU, TLX, BOT, CU6 and little old SNT
A lesser known ASX-listed pharmaceutical player with potential is Syntara, which makes drugs to treat extracellular matrix dysfunction, which can cause cancer, muscular dystrophy and other conditions. It is currently undertaking five separate Phase 2 trials.
“The most advanced trial is in myelofibrosis, which is a rare haematological cancer, with results expected before the end of the year,” says De Silva, who sits on the company’s board. With a relatively small market capitalisation of $41 million, the company is also seen as a potential takeover target. The stock has risen 60 per cent this year, but is trading well off a record high set in July.
10 months into an open trial and the first time using SNT-5505 on top of a jak inhibitor. The company is sifting through data in prep for ASH in December and Hashan throws little old SNT into the mix. Not sure he'd risk his reputation unless he was seeing some positive signs.
Add to My Watchlist
What is My Watchlist?
